Skip to main content
Lucian Chirieac, MD, Pathology, Boston, MA, Brigham and Women's Hospital

LucianRChirieacMD

Pathology • Boston, MA

Pulmonary Pathology, Anatomic Pathology, Surgical Pathology

Professor of Pathology, Harvard Medical School

Join to view full profile

Dr. Chirieac is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Chirieac's full profile

Already have an account?

Summary

  • Since joining the Department of Pathology at Brigham and Women's Hospital, Dr. Chirieac research has significantly impacted the fields of mesothelioma and lung cancer.
    Through systematic investigation, his research has uncovered new concepts regarding the diagnosis, pathogenesis, and molecular characterization of pleural mesothelioma and distinct subtypes of mesothelioma.
    As part of an interdisciplinary scientific group at Brigham and Women's Hospital and Dana Farber Cancer Institute, Dr. Chirieac has also contributed to significant interdisciplinary research collaborations that have expanded our understanding of mesothelioma and lung cancer. These endeavors have resulted in publications of landmark papers in leading medical journals like Nature, Nature Medicine, Nature Genetics, Cell, Cancer Discovery, and Journal of Clinical Oncology.
    Dr. Chirieac has also written many reviews and chapters on the diagnosis and pathogenesis of mesothelioma and lung carcinomas. He authored or co-authored multiple chapters in the 4th edition of the World Health Organization Classification of Tumors of the Lung, Pleura, Thymus and Heart, including chapters on mesothelioma, Nuclear Protein of the Testis carcinoma, lymphoepithelioma-like carcinoma, and rare unclassified lung tumors.
    Over the years, he has been passionately involved in mentoring. His trainees have presented at numerous meetings, have published the work in distinguished journals, and have won prestigious awards.
    He is dedicated to the investigation of pulmonary malignancies, translating histologic and genomic findings from research to clinical practice, therefore improving the diagnosis and treatment of patients with these malignancies, not only at Brigham and Women's Hospital and Dana-Farber Cancer Institute, but around the world. He enjoys teaching diagnostic pathology to trainees and colleagues and strives to model new generations of academic and practicing surgical pathologists into the future.

Education & Training

  • University of Texas M.D. Anderson Cancer Center
    University of Texas M.D. Anderson Cancer CenterSelective Pathology, 2002 - 2003
  • University of Rochester
    University of RochesterResidency, Pathology-Anatomic and Clinical, 1996 - 2002
  • Carol Davila University of Medicine and Pharmacy
    Carol Davila University of Medicine and PharmacyClass of 1991

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2004 - 2025
  • CT State Medical License
    CT State Medical License 2002 - 2024
  • American Board of Pathology Anatomic Pathology & Clinical Pathology

Awards, Honors, & Recognition

  • Medal of the Romanian Government Prime Minister of Romania, 2023
  • National Special Award for Interdisciplinary Research Romanian Research Gala, 2023
  • Scientific Expert in Mesothelioma - Top 0.29% published author worldwide Expertscape, 2023
  • Join now to see all

Publications & Presentations

PubMed

Authored Content

  • Chapter 40 - Lung, Groung-Glass Opacities and Small Masses: Image-Guided ResectionNovember 2022
  • Pathology of Malignant Pleural MesotheliomaNovember 2020
  • Role of Pathology in Treatment of Lung CancerMarch 2020
  • Pathology of Malignant MesotheliomaMarch 2018
  • Chapter 26 - Usual Lung CancersFebruary 2018
  • Biology of Lung Cancer MetastasesNovember 2017
  • Mediastinal Lesions: Diagnostic Pearls for Interpretation of Small Biopsies and CytologyMay 2017
  • Pathology and Molecular Pathology of Lung CancerSeptember 2016
  • Pleural MesotheliomaApril 2016
  • Malignant MesotheliomaJune 2015
  • Targeted Therapies in Lung CancerAugust 2010
  • Diagnostic Studies in Lung CancerApril 2009
  • Join now to see all

Press Mentions

  • Smart Diaspora 2023 with Dr. Lucian Chirieac
    Smart Diaspora 2023 with Dr. Lucian ChirieacMay 31st, 2023
  • Honorary Council for Science, Innovation and Technology
    Honorary Council for Science, Innovation and Technology May 26th, 2023
  • The Ministry of Digitalization has selected its members in the Honorary Council for Science, Innovation and Technology
    The Ministry of Digitalization has selected its members in the Honorary Council for Science, Innovation and TechnologyMay 26th, 2023
  • Join now to see all

Grant Support

  • Pilot Study of Microdevice for Evaluating Drug Response in site in Lung LesionsNational Institutes of Health (NIH)2019–2024
  • Surgical Eligibility and Outcomes in Women with Lung CancerNational Institutes of Health (NIH)2014–2024
  • Genetic and Molecular Analysis of CancerNational Institutes of Health (NIH)2011–2024
  • Non-Small Cell Lung Cancer DatabaseNational Institutes of Health2006–2024
  • Comprehensive Mesothelioma ProjectNational Institutes of Health (NIH)2005–2024

Committees

  • Member, US-Canadian Mesothelioma Reference Panel 2014 - Present
  • Committee Expert, International Committee on Cancer Reporting (ICCR) 2014 - Present
  • Leader of the Respiratory Pathology Cadre, Alliance for Clinical Trials in Oncology by the National Cancer Institute 2010 - Present
  • Permanent Member, International Mesothelioma Interest Group (IMiG) 2010 - Present
  • Permanent Member, National Comprehensive Cancer Network (NCCN) - Non-Small Cell Lung Cancer Panel 2005 - Present

Professional Memberships

  • United States and Canadian Academy of Pathology
    Member
  • College of American Pathologists
    Fellow
  • Pulmonary Pathology Society
    Member
  • International Mesothelioma Interest Group
    Member
  • American Society of Clinical Pathologists
    Fellow
  • International Association for the Study of Lung Cancer
    Member
  • American Association for Cancer Research
    Member
  • American Society of Clinical Oncology
    Member
  • American Medical Association
    Member

Other Languages

  • Romanian, French

Hospital Affiliations

Dr. Lucian Chirieac, Dr. Lucian Chirieac, MD, Dr. L Chirieac, Dr. Lucian R Chirieac